Jan 27, 2021
INVO Bioscience Advances Commercialization into the European Fertility Market with Initial Orders of INVOcell (IVC) in Spain
Jan 15, 2021
INVO Bioscience Expands Distribution of INVOcell Into the Pakistan Infertility Market with Galaxy Pharma Ltd.
Jan 07, 2021
INVO Bioscience Management Letter to Shareholders
Nov 25, 2020
INVO Bioscience and idsMED Group Enter Distribution Agreement for Malaysia
Nov 18, 2020
INVO Bioscience Forms Scientific Advisory Board with Leaders from Fertility Industry
Nov 16, 2020
INVO Bioscience Reports Third Quarter 2020 Financial Results
Nov 12, 2020
INVO Bioscience Announces Pricing of Follow-on Public Offering and Listing on the NASDAQ Capital Market
Sep 30, 2020
INVO Bioscience Establishes Joint Venture to Operate Dedicated INVOcell Fertility Clinics in Mexico
Sep 16, 2020
INVO Bioscience Announces Appointment of Barbara Ryan and Matthew Szot to the Board of Directors
Aug 13, 2020
INVO Bioscience Reports Second Quarter 2020 Financial Results
Aug 06, 2020
INVO Bioscience to Present at the August 2020 Lytham Partners Virtual Investor Growth Conference
Jul 16, 2020
INVO Bioscience Receives Registration Approval for INVOcell in Turkey
Jul 02, 2020
America Institute for Reproductive Medicine of Birmingham Alabama ("AIRM") Spotlights its Success in the Use of INVOcell
Jun 29, 2020
INVO Bioscience Announces Closing of Financing
Jun 23, 2020
INVO Bioscience Now Trading Under "INVO" Ticker Symbol On Tuesday, June 23, 2020
Jun 19, 2020
A Vista Partners Interview with Steve Shum CEO of INVO Bioscience Regarding Increasing Access to Care for Fertility Treatment
May 22, 2020
INVO Bioscience Announces 1-for-20 Reverse Stock Split
May 15, 2020
INVO Bioscience Reports First Quarter 2020 Financial Results
Apr 02, 2020
INVO Bioscience Appoints Christopher Myer as VP Business Development - Americas
Mar 30, 2020
INVO Bioscience Reports 2019 Financial Results